AU2020273307A1 — Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
Assigned to Exelixis Inc · Expires 2020-12-17 · 5y expired
What this patent protects
The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically acceptable salts thereof: (X2) H YN N 0 0 X n 0 H3C-O H3C-O)CN wherein: X 1 is H, Br, Cl, or F; X 2 is H, Br, Cl, or F; nI is 1-2; and …
USPTO Abstract
The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically acceptable salts thereof: (X2) H YN N 0 0 X n 0 H3C-O H3C-O)CN wherein: X 1 is H, Br, Cl, or F; X 2 is H, Br, Cl, or F; nI is 1-2; and n2 is 1-2. 47
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.